I
N the international trial on thromboembolic complications after major surgical procedures, n the 12q-labeled fibrinogen test ra2 revealed the occurrence of postoperative deep vein thrombosis (DVT) in 24.6% of 667 control patients and in 7.7% of 625 heparin-treated patients. Neurosurgical procedures were not considered in that trial. In 1975, Joffe TM reported the results obtained from 23 neurosurgical patients, and found DVT in 43% of them. In his reply to doubts expressed by Coppola, 5 Joffe 9 stated that a distinction should be made between "clinical" and "isotopic" DVT diagnosis. The purpose of our present study was to use the fibrinogen test in patients undergoing elective intracranial surgical procedures in order to investigate the incidence of postoperative DVT and to test the effectiveness of heparin prophylaxis.
Clinical Material and Methods

Assessment of Deep Vein Thrombosis
Deep vein thrombosis was investigated by the fibrinogen test using a Pitman 235 isotope localization monitor.* Radioactive fibrinogen,t I00 ~Ci, was given to each patient 24 hours before operation. At the same time, The series included 110 patients, all over 40 years of age, who were to undergo elective intracranial surgical procedures. To ascertain the real incidence of postoperative DVT, we excluded 10 of these patients who had a positive fibrinogen test before operation? The study was then completed in 100 patients: 50 were randomized to a control group (Group A), and 50 to a heparin group (Group B). The two groups were well matched (Tables 1-3) .
Heparin Treatment
All patients were preoperatively evaluated by prothrombin time, partial thromboplastin time (PTT), thrombin time (TT), and plasma fibrinogen and platelets count. Group B patients were then given 5000 units of calcium heparin subcutaneously. This was considered to be a safe prophylactic dose if the patient's plasma heparin concentration was less than 0.18 units/ml 3 hours after administration? Otherwise, a lower dose was given and the patient's plasma heparin concentration was tested again after 3 hours? ,4 Once established, the safe prophylactic dose was given 2 hours before surgery and every 8 hours thereafter for at least 7 days.
Results
Occurrence of Deep Vein Thrombosis
The incidence of postoperative DVT was 34% in the control group and 6% in the treated group (p < 0.005) ( Table 4) . A positive correlation was observed in control patients between thrombosis and motor deficit (p < 0.05). There were no differences in the transfusion requirements in the two groups (Table 5 ). Postoperative hemoglobin concentration was lower in the treated group, but the difference was not statistically significant (Table 6 ). Three postoperative hematomas were observed, one in the control group and two in the treated group (Table 2) . 
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Heparin Treatment
The standard regime of 5000 units was administered to 46 patients. Average values of PTT, TT, and plasma heparin concentration before and after heparin treatment are listed in Table 7 . A lower dose (3750 units) was used in four patients because the heparin plasma concentration was higher than 0.18 units/ml (range 0.18 to 0.21 units/ml), and because of abnormal values of PTT and/or TT.
Discussion
Our results in neurosurgical patients agree with those reported in general surgery. 11 The incidence of postoperative DVT is high and its prevention is possible by the use of prophylactic heparin treatment. Neurosurgical patients seem to be particularly prone to this complication? ~ The possible factors that could predispose them to develop DVT more frequently than other surgical patients include the positive correlation between thrombosis and motor deficit 14 (Table 4) . It should be remembered that 10 patients who exhibited DVT before operation (eight with DVT in the paretic limb or limbs) were not considered in our study. The prophylactic role of heparin treatment was well demonstrated in our patients by the reduction to 6% of the postoperative DVT.
After treating 150 neurosurgical patients, Barnett, et al., ~ recently reported that "minidose heparin therapy can be used safely and without fear of increased intracranial or intraspinal bleeding." Our data confirm this assumption. No differences were observed in our treated and untreated patients so far as surgical complications, transfusion requirements, and postoperative hematomas are concerned. Nevertheless, the tendency (not statistically significant) for treated patients to have a lower hemoglobin postoperatively, and the occurrence of four cases of unsafe plasma heparin concentrations must be kept in mind. "Minor bleeding" or "wound hematomas" such as occurred in treated patients of the International Trial 11 could be very dangerous in neurosurgery. We think that the preoperative assessment of the patients' sensitivity to the standard dose of heparin could be important in improving the safety of heparin prophylaxis. From the practical point of view, the detection of DVT in the paretic limbs of neurosurgical patients may be relevant in respect to their early mobilization.
